Overexpression of SETMAR is favourable in kidney cancer and unfavourable in liver cancer, while most TCGA cancers have no significant survival association with SETMAR (https://www.proteinatlas.org/ENSG00000170364-SETMAR/pathology). Here, SETMAR is linked to cancer.